top of page
Search

MarketAxess (MKTX)

  • Writer: Abacus Research
    Abacus Research
  • Feb 3, 2023
  • 1 min read

We see an opportunity to own a great long term asset that can compound 10%+. We like everything about MKTX, the high quality, low capital intensity, depressed margins, the recent stock weakness, plus the highly likely cyclical rebound.

  • The market is worried on two fronts:

    1. Tradeweb taking share

    2. Fee compression which is driven by cyclical factors-

  • We think both concerns are overdone. Our 2024 EBITDA estimates are 20% above consensus.

  • The challenge has always been valuation, how much should we pay for this sort of asset? After the derating, we think it is easier than it has been.

Potential Upside: $410-$430 (+27%) Sensible Downside: $275 (-18%)


 
 
 

Recent Posts

See All
RYAN / Insurance Cycle

Ryan (RYAN) is a typical hard market beneficiary, that is going through an organic growth reset. Are we there yet in terms of the reset- probably not. Timing the bottom of a cyclical market is hard. N

 
 
 
Nebius & DigitalOcean: Inference Efficiency

(NBIS, DOCN) 1. The Core AI Thesis At the core of all AI theses there are two beliefs: Demand for intelligence is ~infinite — this still seems to be true, at leas there is no data to the contrary. Com

 
 
 
SEDG, ENPH, NVTS: Plays on 800V

Everybody knows about the 800V conversion that is coming. NVDA etc have released the specs. There are many parts to that ecosystem change. Most of them are not ‘free options’ whereas SEDG and ENPH mos

 
 
 

Comments

bottom of page